HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
Aronson
J K
JK
MRC Unit, Radcliffe Infirmary, Oxford.
Ng
L L
LL
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008148:Lovastatin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D017035:Pravastatin; D019821:Simvastatin
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009281:Naphthalenes; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin